載入...
Dendritic cell-glioma fusion activates T lymphocytes by elevating cytotoxic efficiency as an antitumor vaccine
BACKGROUND: Hybrid cells produced by fusions of tumor and dendritic cells (DC) have demonstrated remarkable efficacy for priming the anti-tumor immune response. In the current study, we examined the antitumor activity of cytotoxic T lymphocytes (CTLs) primed in response to a tumor vaccine comprising...
Na minha lista:
| 發表在: | Cent Eur J Immunol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Polish Society of Experimental and Clinical Immunology
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4439993/ https://ncbi.nlm.nih.gov/pubmed/26155134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2014.45935 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|